2 terminated, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow BHR Pharma, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue 4-OH tamoxifen, Placebo - Mammographic Breast Density | Phase 3 | Terminated | BHR Pharma, LLC | 223 | 2017-08-21 | 2022-07-26 |
| Study of Progesterone in Treatment of Vasomotor Symptoms Progesterone oral capsule, Placebo oral capsule - Menopause Related Conditions | Phase 3 | Terminated | BHR Pharma, LLC | 55 | 2017-08-01 | 2019-03-06 |
| Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury Progesterone, Lipid emulsion without progesterone - Brain Injuries | Phase 3 | Completed | BHR Pharma, LLC | 1195 | 2010-06-01 | 2024-10-02 |
Brain Injuries (1) · Wounds and Injuries (1)
Progesterone (2) · 4,17 beta-dihydroxy-4-androstene-3-one (1)
Germany (3) · Spain (2) · United States (2) · Argentina (1) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · Finland (1) · France (1) · Hungary (1) · Israel (1) · Italy (1) · Malaysia (1) · Netherlands (1)